开心散对双侧海马 CA1 区注射 Aβ1-42 致 AD 大鼠的治疗作用及机制研究
作者:
作者单位:

1.北京中医药大学中药学院,北京 102488;2.北京同仁堂研究院,北京 100071;3.北京市药品检验研究院,北京 102200

作者简介:

通讯作者:

中图分类号:

R-33

基金项目:


Therapeutic effect and mechanisms of Kaixin San in AD rats induced by bilateral Aβ1-42 injection into the CA1 area of the hippocampus
Author:
Affiliation:

1. School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing 102488, China.2. Beijing Tongrentang Research Institute, Beijing 100071. 3. Beijing Institute for Drug Control, Beijing 102200

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 考察开心散对双侧海马 CA1 区注射 Aβ1-42 致 AD 大鼠的治疗效果,初步明晰其作用机制。方法 以“β-淀粉样蛋白毒性学说”为依据,使用脑立体定位仪在 SD 大鼠双侧海马 CA1 区注射 Aβ1-42 寡聚肽段,从而复制 AD 大鼠模型。 将痴呆大鼠随机分为模型组、石杉碱甲组、开心散低剂量组、中剂量组与高剂量组,每组10 只。另取 10 只大鼠颅内注射等量的生理盐水为假手术组,正常大鼠 10 只作为空白对照组。 连续灌胃给药30 d。 通过 Morris 水迷宫行为学测试观测大鼠学习记忆成绩的变化;HE 染色及 Nissl 染色观察脑组织病理形态;ELISA 法检测脑组织中胆碱能神经递质( ACh、AChE、ChAT)、炎症因子( TNF-α、 IL-6、 IL-1β) 及 β-淀粉样蛋白(APP、Aβ1-40 、Aβ1-42 )的含量;IHC 法解析皮层、海马组织中 tau 蛋白及 GSK-3β 的表达水平;Western blot 法察看脑组织中 BAX 与 BCL-2 的表达程度。 结果 与模型组相比,开心散干预组大鼠逃避潜伏期明显缩短,穿越平台次数增多,在目标象限的停留时间及游泳路程所占百分比均有增加(P<0. 05 或 P<0. 01);皮层、海马组织神经元数量增多,形态结构趋于正常,且尼氏小体数量增加,胞浆着色变深;脑组织中 AChE 活性减弱,ChAT 及 ACh 含量明显升高(P<0. 05 或 P<0. 01);TNF-α、IL-6、IL-1β、APP、Aβ1-40 及 Aβ1-42 的含量显著下降(P<0. 05 或 P<0. 01);皮层、海马组织中 tau 蛋白及 GSK-3β 的阳性表达量皆有下调(P<0. 05 或 P<0. 01);BAX 蛋白的表达水平趋于下降,且 BCL-2 / BAX 的比值有不同程度的升高趋势(P>0. 05)。 结论 开心散对 AD 损伤大鼠的痴呆症状与脑组织损伤有较好的治疗效果,其作用机制涉及到胆碱能系统的修复、炎症因子释放的抑制、β-淀粉样蛋白的清除及 tau 蛋白磷酸化水平的调控。

    Abstract:

    To examine the therapeutic effect of Kaixin San in rats with AD caused by bilateral Aβ1-42 injection into CA1 area of the hippocampus, and to preliminarily clarify its mechanisms. Methods Using the “β-amyloid protein toxicity theory”, the rat model of AD was established by bilaterally injecting Aβ1-42 oligopeptide segments in the CA1 region of the hippocampus of SD rats using a brain stereotaxic instrument. The rats were randomly divided into model, Hupezine A, Kaixin San low, middle and high dose groups, with 10 rats in each group. Another 10 rats were subjected to intracranial injection of an equal amount of physiological saline as the sham operation group and 10 normal rats were used as the blank control. The rats were subjected to continuous intragastric administrations for 30 days. Changes in learning and memory performance were observed by the Morris water maze behavioral test. HE and Nissl staining was used to visualize pathological morphology of the brain. The contents of cholinergic neurotransmitters ( ACh, AChE and ChAT ), proinflammatory factors (TNF-α, IL-6 and IL-1β), and β-amyloid protein (APP, Aβ1-40 and Aβ1-42 ) in brain tissue were measured by ELISA. Expression of tau protein and GSK-3β in cortical and hippocampal tissues was detected by IHC. BAX and BCL-2 expression in brain tissues was measured by Western blot. Results Compared with the model group, rats in the Kaixin San treatment groups had a significantly shorter escape latency, an increased number of platform crossings, and an enhanced dwell time and percentage of swimming distance to the total distance in the target quadrant (P<0. 05 or P<0. 01). The numbers of neurons in cortical and hippocampal tissues were increased, the morphological structure tended to be normalized, the number of Nissl bodies increased, and the cytoplasm darkened. AChE activity was attenuated, and ChAT with ACh levels were significantly increased in brain tissue (P<0. 05 or P<0. 01). TNF-α, IL-6, IL-1β, APP,Aβ1-40 and Aβ1-42 contents were decreased markedly (P<0. 05 or P<0. 01). Expression of tau protein and GSK-3β in both cortical and hippocampal tissues was downregulated (P<0. 05 or P<0. 01). BAX protein expression decreased, and the ratio of BCL-2/ BAX tended to increase to various degrees (P>0. 05). Conclusions Kaixin San has a good therapeutic effect on dementia symptoms and brain tissue damage in AD-injured rats, and its mechanisms involve the repair of the cholinergic system, inhibition of proinflammatory factor release, clearance of β-amyloid protein, and regulation of tau protein phosphorylation.

    参考文献
    相似文献
    引证文献
引用本文

裴海鸾,马贝贝,王婷婷,李瑞吉,刘金辉,于尚玥,娄天宇,左泽平,田时秋,李依林,王晨晓,田颖颖,田 骄,赵新月,刘 闯,郭玉东,王 晶,王志斌.开心散对双侧海马 CA1 区注射 Aβ1-42 致 AD 大鼠的治疗作用及机制研究[J].中国比较医学杂志,2022,32(10):78~90.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2021-12-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2023-05-08
  • 出版日期: